Hydroxyprogesterone Caproate is used for reducing the risk of preterm birth in women with a history of singleton spontaneous preterm birth. It was first introduced by Bristol Myers Squibb in its drug Delalutin on Approved Prior to Jan 1, 1982. Other drugs containing Hydroxyprogesterone Caproate are Makena Preservative Free, Makena (Autoinjector), Hydroxyprogesterone Caproate, Makena. 12 different companies have introduced drugs containing Hydroxyprogesterone Caproate.

Hydroxyprogesterone Caproate Patents

Given below is the list of patents protecting Hydroxyprogesterone Caproate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Makena (autoinjector)	US10471075	Methods of reducing risk of preterm birth	May 02, 2036	Covis
Makena (autoinjector)	US11154562	Methods of reducing risk of preterm birth	May 02, 2036	Covis
Makena (autoinjector)	US11304962	Methods of reducing risk of preterm birth	May 02, 2036	Covis
Makena (autoinjector)	US9844558	Methods of reducing risk of preterm birth	May 02, 2036	Covis
Makena (autoinjector)	US9789257	Needle assisted injection device having reduced trigger force	Feb 11, 2034	Covis
Makena (autoinjector)	US11446440	Needle assisted injection device having reduced trigger force	Aug 21, 2031	Covis
Makena (autoinjector)	US8021335	Prefilled syringe jet injector	Oct 04, 2026	Covis
Makena (autoinjector)	US11446441	Prefilled syringe injector	Jan 24, 2026	Covis
Makena (autoinjector)	US8562564	Prefilled syringe jet injector	Jan 24, 2026	Covis
Makena (autoinjector)	US9180259	Prefilled syringe jet injector	Jan 24, 2026	Covis
Makena (autoinjector)	US9533102	Prefilled syringe jet injector	Jan 24, 2026	Covis
Makena (autoinjector)	US9629959	Prefilled syringe jet injector	Jan 24, 2026	Covis
Makena (autoinjector)	USRE44846	Needle assisted jet injector	Aug 10, 2019 (Expired)	Covis

Add above patents to watchlist

Hydroxyprogesterone Caproate's Family Patents

Full family tree

Hydroxyprogesterone Caproate Generic API Manufacturers

Several generic applications have been filed for Hydroxyprogesterone Caproate. The first generic version for Hydroxyprogesterone Caproate was by Aspen Global Inc and was approved on Aug 24, 2015. And the latest generic version is by American Regent Inc and was approved on Aug 9, 2019.

Given below is the list of companies who have filed for Hydroxyprogesterone Caproate generic, along with the locations of their manufacturing plants worldwide.